Loading...
Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
Among the pharmaceutical options available for treatment of ovarian cancer, increasing attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation prolongs the persistence of the drug in the circulation and potentiates intratumor accumulation. Pegylate...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Hindawi Publishing Corporation
2013
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3612436/ https://ncbi.nlm.nih.gov/pubmed/23577259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/898146 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|